stars 1 stars 2 stars 3

Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at and follow @ScholarRock and on LinkedIn.

View Top Employees from Scholar Rock
Ticker SRRK
Revenue $47.3 million
Funding $726 million
Employees 156 (156 on RocketReach)
Founded 2012
Address 301 Binney St, Cambridge, Massachusetts 02142, US
Phone (857) 259-3860
Fax (866) 493-4935
JavaScript, HTML, PHP +47 more (view full list)
Category Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Medical, Health Care, Therapeutics
Web Rank 7 Million
Keywords scholar rock, scholar rock holding corp, scholar rock holding corporation, scholar rock holding corp., scholar rock therapeutics
Competitors Aura Biosciences, GlycoMimetics, Harpoon Therapeutics, Pliant Therapeutics, Vedanta Biosciences, Inc.
SIC 87, 873
NAICS 541, 54, 5417, 541712, 54171, 541711

Scholar Rock Questions

The Scholar Rock annual revenue was $47.3 million in 2023.

Ted Myles is the Chief Operating Officer and Chief Financial Officer of Scholar Rock.

156 people are employed at Scholar Rock.

Scholar Rock is based in Cambridge, Massachusetts.

The NAICS codes for Scholar Rock are [541, 54, 5417, 541712, 54171, 541711].

The SIC codes for Scholar Rock are [87, 873].

Top Scholar Rock Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users